Johnson, A., Zhao, Y., Qiao, X., Dolan, J. G., Berghuijs, K. V. T., Talano, J., Kitko, C., Chaudhury, S., Dvorak, C., Lalefar, N., Bunin, N., Kapoor, N., Anderson, E., Bertaina, A., Flower, A., Pulsipher, M., Abdel-Azim, H. (2025). Bone marrow next generation sequencing minimal residual disease (NGS-MRD) positivity pre-allogeneic hematopoietic cell transplantation (HCT) predicts outcomes for patients with B-cell acute lymphoblastic leukemia (B-ALL): A planned analysis from the ptctc ONC1401 trial. Blood. https://doi.org/10.1182/blood-2025-511